製品名:(1r,3r)-3-(1H-1,2,3-triazol-1-yl)cyclobutane-1-carboxylic acid hydrochloride

IUPAC Name:(1r,3r)-3-(1H-1,2,3-triazol-1-yl)cyclobutane-1-carboxylic acid hydrochloride

CAS番号:2228779-05-1
分子式:C7H10ClN3O2
純度:95%+
カタログ番号:CM463508
分子量:203.63

包装単位 有効在庫 価格(USD) 数量
CM463508-250mg 4-5 Weeks ȅƚƐ
CM463508-500mg 4-5 Weeks ǫŸƚ
CM463508-1g 5-6 Weeks ŸdžƐƚ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:2228779-05-1
分子式:C7H10ClN3O2
融点:-
SMILESコード:Cl.OC(=O)[C@H]1C[C@@H](C1)N1C=CN=N1
密度:
カタログ番号:CM463508
分子量:203.63
沸点:
MDL番号:MFCD31666534
保管方法:

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.
Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.

Related Products